Advisory Council for the Elimination of Tuberculosis, 28479-28480 [E8-10993]
Download as PDF
<![CDATA[
28479
Federal Register / Vol. 73, No. 96 / Friday, May 16, 2008 / Notices
ways to enhance the quality, utility, and
clarity of the information to be
collected; and (d) ways to minimize the
burden of the collection of information
on respondents, including through the
use of automated collection techniques
or other forms of information
technology. Written comments should
be received within 60 days of this
notice.
Proposed Project
National Survey of HIV Testing in
Hospitals—New—National Center for
HIV, Viral Hepatitis, STD and TB
Prevention (NCHHSTP), Centers for
Disease Control and Prevention (CDC).
Background and Brief Description
Early identification of HIV infection
has significant benefits to the infected
individual and society. In light of recent
advancements in HIV testing and
treatment, the Centers for Disease
Control and Prevention (CDC) released
its prevention initiative, Advancing HIV
Prevention: New Strategies for a
Changing Epidemic. A key component
of this strategy focuses upon increased
HIV testing in healthcare settings to
increase the number of persons with
HIV who are aware of their infection
and are successfully referred to
treatment and prevention services. In
September 2006, CDC released revised
recommendations for routine HIV
CDC is requesting approval for a 2year clearance for data collection. This
project will collect data from hospitals
on a one-time voluntary basis using a
brief survey. Surveys will be completed
by the hospital administrators at each
site who are most knowledgeable on
HIV testing practices, infection control,
and laboratory procedures for their site,
in consultation with other hospital staff,
as necessary. Collection of data will
provide information on current HIV
testing practices and policies for the
hospital; use of point-of-care and
conventional HIV tests; and barriers and
facilitators of hospital-based HIV
testing.
Data will be requested from a
representative sample of 4,927 U.S.
community hospitals. Surveys will be
sent to approximately 1,000 hospital
sites with an estimated 70% response
rate, based upon estimates from
response rates from prior similar
surveys among U.S. hospitals. This will
result in approximately 700
participating hospital sites, representing
approximately 15% of U.S. community
hospitals. The average duration of the
survey, including time required to
collect the requested data, is estimated
to be 4 hours per hospital site. There is
no cost to the participating hospitals
other than their time.
testing of adults, adolescents, and
pregnant women in healthcare settings
as a measure to address the high number
of individuals who are unaware of their
HIV infection.
Routine HIV testing programs in
hospital settings, including emergency
departments (EDs) and urgent care
centers (UCCs), have great potential to
identify a large number of previously
undiagnosed individuals. Prior to the
release of the revised recommendations,
few such hospital-based testing
programs had existed in the United
States. CDC is committed to increasing
the number of such programs in the
U.S., and is currently working with
partners to achieve these goals. This
project proposes a survey to assess HIV
testing policies and practices in
hospitals nationwide and to describe the
up-take of the revised HIV testing
recommendations for hospital settings.
The objectives of this project are: (1)
To determine the extent to which HIV
testing is being conducted in U.S.
hospitals; (2) to describe the
characteristics of hospitals with and
without HIV testing programs; and (3) to
identify barriers to and facilitators of
implementing HIV testing programs in
these settings. This data will assist CDC
in monitoring the uptake of
recommendations for HIV testing in
healthcare settings.
ESTIMATED ANNUALIZED BURDEN HOURS
Number of
respondents
Type of form
Average
burden
per response
in hours
Number of
responses per
respondent
Total burden
in hours
Hospital Survey ................................................................................................
700
1
4
2,800
Total ..........................................................................................................
........................
........................
........................
2,800
Dated: May 8, 2008.
Maryam I. Daneshvar,
Acting Reports Clearance Officer, Centers for
Disease Control and Prevention.
[FR Doc. E8–10935 Filed 5–15–08; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
sroberts on PROD1PC70 with NOTICES
Centers for Disease Control and
Prevention
Advisory Council for the Elimination of
Tuberculosis
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
VerDate Aug<31>2005
16:18 May 15, 2008
Jkt 214001
announces the following council
meeting.
Name: Advisory Council for the
Elimination of Tuberculosis
Times and Dates:
8:30 a.m.–5 p.m., June 17, 2008.
8:30 a.m.–2 p.m., June 18, 2008.
Place: Corporate Square, Building 8, 1st
Floor Conference Room, Atlanta, Georgia
30333, telephone (404) 639–8317.
Status: Open to the public, limited only by
the space available. The meeting room
accommodates approximately 100 people.
Purpose: This council advises and makes
recommendations to the Secretary of Health
and Human Services, the Assistant Secretary
for Health, and the Director, CDC, regarding
the elimination of tuberculosis. Specifically,
the Council makes recommendations
regarding policies, strategies, objectives, and
priorities; addresses the development and
application of new technologies; and reviews
PO 00000
Frm 00056
Fmt 4703
Sfmt 4703
the extent to which progress has been made
toward eliminating tuberculosis.
Matters to be Discussed: Agenda items
include issues pertaining to the Findings
from the Philippine Technical Instruction
Program Review; Division of Tuberculosis
Training, Informatics, Surveillance and
Research Issues; and Discussion on the Office
of Management and Budget (OMB) and
Genomics, and other related Tuberculosis
Issues.
Agenda items are subject to change as
priorities dictate.
Contact Person for More Information:
Margie Scott-Cseh, Coordinating Center for
Infectious Diseases, Strategic Business Unit,
1600 Clifton Road, NE., M/S E–07, Atlanta,
Georgia 30333, telephone (404) 639–8317.
The Director, Management Analysis and
Services Office, has been delegated the
authority to sign Federal Register Notices
pertaining to announcements of meetings and
other committee management activities, for
E:\FR\FM\16MYN1.SGM
16MYN1
28480
Federal Register / Vol. 73, No. 96 / Friday, May 16, 2008 / Notices
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Disease, Disability, and Injury
Prevention and Control Special
Emphasis Panel (SEP): Preparedness
and Emergency Response Research
Centers: A Public Health System
Approach, Program Announcement
Number (PA) TP 08–001
sroberts on PROD1PC70 with NOTICES
In accordance with Section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces the aforementioned meeting.
Times and Dates:
7 p.m.–9:30 p.m., July 7, 2008 (Closed).
8:30 a.m.–5:30 p.m., July 8, 2008 (Closed).
8:30 a.m.–5:30 p.m., July 9, 2008 (Closed).
7 p.m.–9:30 p.m., July 9, 2008 (Closed).
8:30 a.m.–5:30 p.m., July 10, 2008 (Closed).
8:30 a.m.–5:30 p.m., July 11, 2008 (Closed).
Place: Spring Hill Suites Marriott, 3459
Buckhead Loop, Atlanta, GA 30326,
Telephone (404) 844–4800.
Status: The meeting will be closed to the
public in accordance with provisions set
forth in Section 552b(c) (4) and (6), Title 5
U.S.C., and the Determination of the Director,
Management Analysis and Services Office,
CDC, pursuant to Public Law 92–463.
Matters to be Discussed: The meeting will
include the review, discussion, and
evaluation of applications received in
response to ‘‘Preparedness and Emergency
Response Research Centers: A Public Health
System Approach,’’ PA TP 08–001.
Contact Person for More Information:
Charles Rafferty, Ph.D., Senior Scientific
Review Officer, Office of Science and Public
Health Practice, Coordinating Office for
Terrorism Preparedness and Emergency
Response, CDC, 1600 Clifton Road NE.,
Mailstop D44, Atlanta, GA 30333, Telephone
(404) 639–7495.
The Director, Management Analysis and
Services Office, has been delegated the
authority to sign Federal Register notices
pertaining to announcements of meetings and
other committee management activities, for
both CDC and the Agency for Toxic
Substances and Disease Registry.
VerDate Aug<31>2005
16:18 May 15, 2008
Jkt 214001
Dated: May 9, 2008.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. E8–10991 Filed 5–15–08; 8:45 am]
BILLING CODE 4163–18–P
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Healthcare Infection Control Practices
Advisory Committee
Dated: May 9, 2008.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. E8–10993 Filed 5–15–08; 8:45 am]
Dated: May 9, 2008.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. E8–10974 Filed 5–15–08; 8:45 am]
Centers for Disease Control and
Prevention
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Statement of Organization, Functions,
and Delegations of Authority
In accordance with section 10(a) (2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces the following meeting for the
aforementioned committee:
Name: Healthcare Infection Control
Practices Advisory Committee (HICPAC).
Times and Dates:
9 a.m.–5 p.m., June 12, 2008.
9 a.m.–1 p.m., June 13, 2008.
Place: Centers for Disease Control and
Prevention, 1600 Clifton Road, Global
Communications Center, Building 19,
Auditorium B3, Atlanta, Georgia 30333.
Status: Open to the public, limited only by
the space available.
Purpose: The Committee is charged with
providing advice and guidance to the
Secretary, the Assistant Secretary for Health,
the Director, CDC, and the Director, National
Center for Preparedness, Detection, and
Control of Infectious Diseases (NCPDCID),
regarding (1) the practice of hospital
infection control; (2) strategies for
surveillance, prevention, and control of
infections (e.g., nosocomial infections),
antimicrobial resistance, and related events
in settings where healthcare is provided; and
(3) periodic updating of guidelines and other
policy statements regarding prevention of
healthcare-associated infections and
healthcare-related conditions.
Matters to be Discussed: Guidelines and
progress including prevention of UTI and
Norovirus transmission, HICPAC
prioritization of recommendations for
implementation. Agenda items are subject to
change as priorities dictate.
Contact Person for More Information:
Wendy Vance, HICPAC, Division of
Healthcare Quality Promotion, NCPDCID,
CDC, l600 Clifton Road, NE., Mailstop D–10,
Atlanta, Georgia 30333. Telephone (404)
639–2891.
The Director, Management Analysis and
Services Office, has been delegated the
authority to sign Federal Register notices
pertaining to announcements of meetings and
other committee management activities, for
both CDC and the Agency for Toxic
Substances and Disease Registry.
PO 00000
Frm 00057
Fmt 4703
Sfmt 4703
Part C (Centers for Disease Control
and Prevention) of the Statement of
Organization, Functions, and
Delegations of Authority of the
Department of Health and Human
Services (45 FR 67772–76, dated
October 14, 1980, and corrected at 45 FR
69296, October 20, 1980, as amended
most recently at 73 FR 20297–304, dated
April 15, 2008) is amended to reflect the
reorganization of the Financial
Management Office within the Office of
the Chief Operating Officer, Centers for
Disease Control and Prevention.
Section C–B, Organization and
Functions, is hereby amended as
follows: Delete in their entirety the titles
and functional statements for the
Financial Management Office (CAJE),
and insert the following:
Financial Management Office (CAJE).
(1) Provides leadership and
coordination in the development and
administration of the Centers for Disease
Control and Prevention’s (CDC)
financial management policies; (2)
develops budget submissions for the
CDC; (3) collaborates with the CDC
Office of the Director (OD) in the
development and implementation of
long-range program and financial plans;
(4) participates in budget reviews and
hearings; (5) manages CDC’s system of
internal budgetary planning and control
of funds; (6) develops and implements
CDC-wide budgetary, accounting, and
fiscal systems and procedures; (7)
conducts CDC-wide manpower
management (including productivity
measurement) activities; (8) prepares
financial reports; (9) serves as the focal
point for domestic and international
travel policy, procedures and
interpretation; (10) provides legislation
reference services; (11) plans, directs
and conducts internal quality assurance
reviews; (12) analyzes data and makes
recommendations to assure effective
safeguards are in place to prevent fraud,
waste and abuse; (13) assists in
identifying or conducting special
E:\FR\FM\16MYN1.SGM
16MYN1
]]>Agencies
[Federal Register Volume 73, Number 96 (Friday, May 16, 2008)]
[Notices]
[Pages 28479-28480]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E8-10993]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Advisory Council for the Elimination of Tuberculosis
In accordance with section 10(a)(2) of the Federal Advisory
Committee Act (Pub. L. 92-463), the Centers for Disease Control and
Prevention (CDC) announces the following council meeting.
Name: Advisory Council for the Elimination of Tuberculosis
Times and Dates:
8:30 a.m.-5 p.m., June 17, 2008.
8:30 a.m.-2 p.m., June 18, 2008.
Place: Corporate Square, Building 8, 1st Floor Conference Room,
Atlanta, Georgia 30333, telephone (404) 639-8317.
Status: Open to the public, limited only by the space available.
The meeting room accommodates approximately 100 people.
Purpose: This council advises and makes recommendations to the
Secretary of Health and Human Services, the Assistant Secretary for
Health, and the Director, CDC, regarding the elimination of
tuberculosis. Specifically, the Council makes recommendations
regarding policies, strategies, objectives, and priorities;
addresses the development and application of new technologies; and
reviews the extent to which progress has been made toward
eliminating tuberculosis.
Matters to be Discussed: Agenda items include issues pertaining
to the Findings from the Philippine Technical Instruction Program
Review; Division of Tuberculosis Training, Informatics, Surveillance
and Research Issues; and Discussion on the Office of Management and
Budget (OMB) and Genomics, and other related Tuberculosis Issues.
Agenda items are subject to change as priorities dictate.
Contact Person for More Information: Margie Scott-Cseh,
Coordinating Center for Infectious Diseases, Strategic Business
Unit, 1600 Clifton Road, NE., M/S E-07, Atlanta, Georgia 30333,
telephone (404) 639-8317.
The Director, Management Analysis and Services Office, has been
delegated the authority to sign Federal Register Notices pertaining
to announcements of meetings and other committee management
activities, for
[[Page 28480]]
both the Centers for Disease Control and Prevention and the Agency
for Toxic Substances and Disease Registry.
Dated: May 9, 2008.
Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease
Control and Prevention.
[FR Doc. E8-10993 Filed 5-15-08; 8:45 am]
BILLING CODE 4163-18-P
